The human TREK-2 (NM_138318)- and TREK-1 (NM_014217) -expressing vector (pGH19-TREK-2) was constructed as described19. On the basis of this vector, point Mutations and deletions were engineered using the MutanBEST kit (TaKaRa, Dalian, China)-guided high-fidelity PCR. All the mutations were confirmed by DNA sequencing. All the Plasmids were linearized by Xho I before in vitro transcription. cRNA was synthesized using the RiboMAX™ Large Scale RNA Production Systems (Promega, Madison, WI) kit.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.